(Q39794442)

14 September 2017

title

[11C]Gefitinib ([11c]Iressa): radiosynthesis, in vitro uptake, and in vivo imaging of intact murine fibrosarcoma (English)

1 reference

14 September 2017

1 reference

Ming-Rong Zhang

1

1 reference

14 September 2017

Katsushi Kumata

2

1 reference

14 September 2017

Akiko Hatori

3

1 reference

14 September 2017

Nobuhiko Takai

4

1 reference

14 September 2017

Jun Toyohara

5

1 reference

14 September 2017

Tomoteru Yamasaki

6

1 reference

14 September 2017

Kazuhiko Yanamoto

7

1 reference

14 September 2017

Joji Yui

8

1 reference

14 September 2017

Kazunori Kawamura

9

1 reference

14 September 2017

Sachiko Koike

10

1 reference

14 September 2017

Koichi Ando

11

1 reference

14 September 2017

Kazutoshi Suzuki

12

1 reference

14 September 2017

publication date

26 September 2009

1 reference

Molecular Imaging and Biology

14 September 2017

published in

1 reference

14 September 2017

volume

12

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

181-191

1 reference

https://scigraph.springernature.com/pub.10.1007/s11307-009-0265-5

14 September 2017

exact match

0 references

cites work

DCEMRI monitoring of canine tumors during fractionated radiotherapy

1 reference

12 December 2020

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

1 reference

12 December 2020

4-anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitors

1 reference

12 December 2020

CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience

1 reference

12 December 2020

Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation

1 reference

12 December 2020

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.

1 reference

12 December 2020

Rational design of potent and selective EGFR tyrosine kinase inhibitors as anticancer agents

1 reference

12 December 2020

Sensitive measurement of positron emitters eluted from HPLC.

1 reference

12 December 2020

11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer

1 reference

12 December 2020

ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells

1 reference

12 December 2020

Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer

1 reference

12 December 2020

Relative biological effectiveness of 290 MeV/u carbon ions for the growth delay of a radioresistant murine fibrosarcoma

1 reference

12 December 2020

[(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy

1 reference

12 December 2020

Nuclear medicine imaging to predict response to radiotherapy: a review

1 reference

12 December 2020

Independent effect of a mixed-beam regimen of fast neutrons and gamma rays on a murine fibrosarcoma.

1 reference

12 December 2020

Cancer molecular imaging: radionuclide-based biomarkers of the epidermal growth factor receptor (EGFR).

1 reference

12 December 2020

Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy

1 reference

12 December 2020

Clinical Results of Carbon Ion Radiotherapy at NIRS

1 reference

12 December 2020

EGFR, HER2 and VEGF pathways: validated targets for cancer treatment

1 reference

12 December 2020

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

12 December 2020

Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).

1 reference

12 December 2020

Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

1 reference

12 December 2020

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors

1 reference

12 December 2020

PET Screening of Anticancer Drugs: A Faster Route to Drug/Target Evaluations In Vivo

1 reference

12 December 2020

EGF receptor in neoplasia and metastasis

1 reference

12 December 2020

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo

1 reference

12 December 2020

Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer

1 reference

12 December 2020

Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptors.

1 reference

12 December 2020

Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

1 reference

12 December 2020

Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice

1 reference

12 December 2020

ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

1 reference

12 December 2020

Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas

1 reference

12 December 2020

Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.

1 reference

12 December 2020

Imaging of cell proliferation: status and prospects

1 reference

12 December 2020

10.1007/S11307-009-0265-5

Identifiers

DOI

1 reference

14 September 2017

1 reference